Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2024年10月15日

• Yanhua Song,
• Wei Shu,
• Yi Pei,
• Juan Du,
• Guihui Wu,
• Hua Wang,
• Fengling Mi,
• Fangchao Liu,
• Liping Ma,
• Li Xie,
• Zhongshun Kong,
• Xiaoguang Wu,
• Rongmei Liu,
• Hongmei Chen,
• Hua Li,
• Qiping Ge,
• Lihui Nie,
• Zizheng Lv,
• Xuerui Huang,
• Mingwu Li,
• Mingying Jiang,
• Xiaohong Chen,
• Qingshan Cai,
• Wei Chen,
• Yanmei Liu,
• Yanfang Miao,
• Yan Tang,
• Yu Chen,
• Shujun Geng,
• Quanying Zhou,
• Yuhong Liu,
• Yu Pang,
• Mengqiu Gao